L. Novotny et al., EFFECT OF ARABINOSYLCYTOSINE DERIVATIVE CYCLOCYTIDINE ON HEPATAL FUNCTIONS IN RATS AND ON ZAJDELA-HEPATOMA, General pharmacology, 25(1), 1994, pp. 201-204
1. The effectivity of the arabinosylcytosine (araC) derivative, cycloc
ytidine (cC), against Zajdela hepatoma was evaluated. It was establish
ed that the cC effect was dose-dependent. 2. Zajdela hepatoma-bearing
rats, given a single dose of 500 mg of cC per kg of body weight, showe
d an increased life span of 48 and 39%. 3. cC significantly decreased
the number of Zajdela hepatoma cells in ascitic fluid and affected the
cytochrome content in hepatal mitochondria. 4. The overall cC effect
on the hepatal function of normal and hepatectomized liver was margina
l, thus making this araC derivative an interesting candidate for furth
er evaluation of its effectivity against non-hematological tumors.